Clinical effectiveness and safety of dimethyl fumarate for patients treated at least 6 years in the swedish post-market surveillance study "immunomodulation and multiple sclerosis epidemiology 5" (IMSE 5)

L. Forsberg, E. Ekstrom,J. Hillert, P. Nilsson,C. Dahle, A. Svenningsson, J. Lycke, A. -M. Lantblom,J. Burman,C. Martin, P. Sundstrom,M. Gunnarsson,F. Piehl,T. Olsson

MULTIPLE SCLEROSIS JOURNAL(2022)

引用 0|浏览2
暂无评分
AI 理解论文
溯源树
样例
生成溯源树,研究论文发展脉络
Chat Paper
正在生成论文摘要